United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo
United Therapeutics (NASDAQ:UTHR | UTHR Price Prediction) surged more than 12% in pre-market trading on March 30 after positive TETON-1 trial data triggered price target raises from two major Wall Street firms. The results…



















